Skin disease evolution under the microscope: a 17-Year look at what drives severity
NCT ID NCT07708896
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study follows 5,000 people with common inflammatory skin conditions—like eczema, psoriasis, and hidradenitis suppurativa—over up to 17 years to see how their disease severity changes. Researchers will collect medical history, treatments, and symptom scores to identify factors that lead to better or worse outcomes. The goal is to understand the natural course of these diseases and what predicts a severe or mild future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Agostino Gemelli IRCCS
Rome, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill quiet the immune attack behind psoriasis?
- Could a common antibiotic boost eczema treatment?
- Laser boost for stubborn psoriasis on hands and feet
- New biologic drug aims to clear stubborn eczema in just 24 weeks
- New oral pill HPP737 takes on psoriasis in Head-to-Head trial
- New oral pill HPP737 aims to clear psoriasis in phase 3 trial